THU0189 Therapeutic Drug Monitoring (TDM) in Rheumatic Day Clinic Enables to Reduce Pharmaceutical Cost Maintaining Clinical Efficacy
Pascual-Salcedo, D., Plasencia, C., Gonzalez del Valle, L., López Casla, T., Arribas, F., Villalba, A., Bonilla, G., López Granados, E., Martín Mola, E., Balsa, A.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
THU0219 The Infliximab Dose Increase is Not Correlated with Clinical Improvement in RA Patients
López-Casla, M. T., Pascual-Salcedo, D., Plasencia, C., Alcozer, P., García-Carazo, S., Bonilla, G., Villalba, A., Peiteado, D., Arribas, F., Martín-Mola, E., Balsa, A.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
AB0280 Imnunogenicity and clinical practice in patients treated with anti-tnf therapy
Alcocer, P., Plasencia, C., Pascual, D., Garcia Carazo, S., Franco, K. N., Cagijas, D., Lojo, L., Bonilla, G., Nuño, L., Villalba, A., López Casla, M. T., Balsa, A., Martín Mola, E.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
THU0171 Influence of Immunogenicity of Anti-TNF Therapy in RA Patients with a Long-Term Treatment with Infliximab or Adalimumab
Villalba, A., Plasencia, C., Peiteado, D., Nuño, L., Bonilla, G., Lojo, L., Pascual, D., del Moral, R., López Casla, M. T., Balsa, A., Martin Mola, E.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
AB0573 The immunogenicity of biological therapies correlates with clinical efficacy in psoriatic arthritis (psa) in long-term treatment with infliximab and adalimumab
Cajigas, D., Plasencia, C., Pascual-Salcedo, D., Bonilla, G., Alcocer, P., García-Carazo, S., Franco, K. N., Lojo, L., Nuño, L., Villalba, A., Peiteado, D., Ramiro, S., López-Casla, M. T., Díez, J., Martín-Mola, E., Balsa, A.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab
Plasencia, Ch, Pascual-Salcedo, D, Alcocer, P, Bonilla, M G, Villalba, A, Peiteado, D, Arribas, F, Díez, J, Lopez-Casla, M T, Martín-Mola, E, Balsa, A
Published in Annals of the rheumatic diseases (01.11.2013)
Published in Annals of the rheumatic diseases (01.11.2013)
Get full text
Journal Article
FRI0168 Etanercept serum trough levels are correlated with clinical activity in rheumatoid arthritis patients with long-term treatment with etanercept
Plasencia, C., Pascual-Salcedo, D., Alcozer, P., Garcia-Carazo, S., Franco, K. N., Cajigas, D., Bonilla, G., Lojo, L., Nuño, L., Villalba, A., Peiteado, D., Arribas, F., Lopez-Casla, M. T., Martin-Mola, E., Balsa, A.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
FRI0310 Tocilizumab Levels Are Associated with Clinical Response in Patients with Rheumatoid Arthritis
Kneepkens, E.L., Van Den Oever, I.A., Plasencia, C., Salcedo Pascual, D., Lopez-Casla, M.T., Van Der Kleij, D., Nurmohamed, M.T., Rispens, T., Balsa, A., Wolbink, G.J.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article